You are viewing the site in preview mode
Skip to main content
|
Adverse Event
|
MSC Group (n = 9)
|
Control Group (n = 9)
|
|---|
|
Grade 1/2 No. (%)
|
Grade 3/4 No. (%)
|
Grade 1/2 No. (%)
|
Grade 3/4 No. (%)
|
|---|
|
Hepatotoxicity
|
0
|
0
|
0
|
0
|
|
Renal failure
|
0
|
0
|
0
|
0
|
|
Nausea
|
0
|
0
|
0
|
0
|
|
Diarrhea
|
0
|
0
|
0
|
0
|
|
Oral mucositis
|
1 (11)
|
0
|
0
|
0
|
|
Arrythmia
|
0
|
0
|
0
|
0
|
|
Heart failure
|
0
|
0
|
0
|
0
|
|
Hypertension
|
0
|
0
|
0
|
0
|
|
Pericarditis
|
0
|
0
|
0
|
0
|
|
Peripheral neuropathy
|
0
|
0
|
0
|
0
|
|
Infections
|
0
|
1 (11)
|
0
|
1 (11)
|
|
Anaphylaxis (including drug fever)
|
3 (33)
|
1 (11)
|
0
|
0
|
|
Local phlebitis
|
0
|
0
|
0
|
0
|
|
Fatigue
|
0
|
0
|
0
|
0
|
|
Headache
|
0
|
0
|
0
|
0
|
|
Fingernail changes
|
0
|
0
|
0
|
0
|
